Early Access — free while we kick the tires
EdgarHawk

Carruthers R Michael

Chief Financial Officer

Officer
1 filing analyzed · 1 company · Latest 2024-09-24

Companies

Company Buys Sells Direction
Edgewise Therapeutics, Inc. EWTX 0 6 Net selling

Activity

September 2024
high
Sell
125,092 shares
$3,573,980
Significance 7/10

CFO Carruthers sold 125,092 shares ($3.6M) at $28.57 avg, reducing stake 94.8%; stock down 12.1% from 52-week high post-sale.

Carruthers, EWTX's Chief Financial Officer, executed 4 separate sales on 2024-09-20 totaling 125,092 shares for $3,573,979.93, liquidating 94.8% of his holdings and leaving only 6,904 shares. The CFO sold near the stock's 52-week high of $29.50, with transaction prices averaging $28.57; the stock has since declined to $25.92 (-12.1% from peak). Notably, his cross-ticker track record shows 100% well-timed sell rate across 1 prior transaction (90-day return of -4.4%), and his same-ticker history from a prior EWTX sale on 2024-01-23 also demonstrated well-timed exit characteristics. However, context matters: the company reported a full-year net income of $-31,497,000.00 and remains unprofitable, which may constrain the stock's risk profile and influence senior executive capital allocation decisions independent of near-term market timing.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access